Total (n = 42) | Partially industry sponsored (n = 10) | Fully industry sponsored (n = 32) | |
---|---|---|---|
Type of trial | |||
Multi-centre | 39 trials (93%) | 9 trials (90%) | 30 trials (94%) |
Single centre | 3 trials (7%) | 1 trial (10%) | 2 trials (6%) |
Planned sample size | |||
Median | 576 participants | 275 participants | 641 participants |
Interquartile range | 361–1130 participants | 172–781 participants | 407–1217 participants |
Type of intervention examined | |||
Drug | 29 trials (69%) | 2 trials (20%) | 27 trials (84%) |
Device | 6 trials (14%) | 2 trials (20%) | 4 trials (13%) |
Surgery | 1 trial (2%) | 0 trials (0%) | 1 trial (3%) |
Other | 6 trials (14%) | 6 trials (60%) | 0 trials (0%) |